Jay Wasman - Concepedia

Author

Jay Wasman

Also Known As

J Wasman, J. K. Wasman, J. WASMAN, J. Wasman, J.K. WASMAN, J.K. Wasman, JAY WASMAN, Jay K Wasman, Jay K. Wasman, Jay Wasman

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Case Western Reserve University University Hospitals of Cleveland University Hospitals Cleveland Medical Center University School West Virginia University

About

Jay Wasman is an author at Case Western Reserve University specializing in medicine, pathology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	558
2	Health Sciences	7	7	172
3	Engineering	1	1	53
4	Natural Sciences	1	1	47
5	Biomedical Engineering	1	1	53

Jay Wasman

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid P. Savvides, Govardhanan Nagaiah, Pierre Lavertu, Thyroid	2012	213
A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome Colin Mooney, Govardhanan Nagaiah, Pingfu Fu, Thyroid	2009	182
A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers Joseph Baar, Paula Silverman, Janice A. Lyons, Clinical Cancer Research	2009	96
Autologous Blood Donation for Elective Surgery Jay Wasman JAMA Transplantation SurgeryTransplantationAutologous Blood DonationMedicineTransfusion Medicine	1987	84
Tissue‐Engineered Calcium Alginate Patches in the Repair of Chronic Chinchilla Tympanic Membrane Perforations David E. Weber, Maroun T. Semaan, Jay Wasman, The Laryngoscope	2006	66
Metastatic Crohn Disease: A Rare Cutaneous Entity Alan Siroy, Jay Wasman Archives of Pathology & Laboratory Medicine Connective Tissue DiseaseMetastatic Crohn DiseaseCrohn DiseaseHistopathologyGastroenterology	2012	63
Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck Min Yao, Nicholas Galanopoulos, Pierre Lavertu, Head & Neck	2014	54
Comparison of cell block preparation methods for nongynecologic ThinPrep specimens Kelly Nigro, Zofia Tynski, Jay Wasman, Diagnostic Cytopathology ImmunohematologyFilter SedimentationEngineeringBlood CellPathology	2007	53
Novel Phase I Dose De-escalation Design Trial to Determine the Biological Modulatory Dose of the Antiangiogenic Agent SU5416 Afshin Dowlati, Kelly M. Robertson, Tomas Radivoyevitch, Clinical Cancer Research	2005	49
Inflammatory Breast Cancer as a Model Disease to Study Tumor Angiogenesis: Results of a Phase IB Trial of Combination SU5416 and Doxorubicin Beth Overmoyer, Pingfu Fu, Charles L. Hoppel, Clinical Cancer Research	2007	49

Page 1